echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > HAEMOPHILIA: Observation of pathological changes and expression of ligaments in patients with hemophilic arthritis

    HAEMOPHILIA: Observation of pathological changes and expression of ligaments in patients with hemophilic arthritis

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Hemophilic arthritis (HA) is the most common and most serious complication in patients with hemophilia, which can lead to advanced joint dysfunction and disability
    .
    Previous studies on the pathological mechanism of HA focused on synovial bone, cartilaginous bone and subchondral bone lesions


    .


    Haemophilic arthritis (HA) is the most common and serious complication in patients with hemophilia, which can lead to advanced joint dysfunction and prevention of disability

    A foreign research team conducted a study to observe the levels of lysine oxidase (LOX) and matrix metalloproteinase (MMP) -1, -2, and -3 in the ligament tissues of HA patients and osteoarthritis (OA) patients.
    The pathological changes were designed to explore the changes in the levels of lysine oxidase (LOX) and matrix metalloproteinases (MMP)-1, -2, and -3 in the ligament tissues of patients with HA
    .

    Osteoarthritis

    The study used Masson's trichrome staining method, verhoff-van Gieson staining method, and hematoxylin-eosin staining method to observe the basic pathological changes of ligaments
    .
    Western blot was used to detect the expression levels of type I collagen, elastin, LOXs and MMP-1, -2, -3


    .


    The results show that compared with OA ligaments, HA ligaments have looser structures, wider gaps, more breaks, blood cell deposition and local hypertrophy between fibers
    .
    The expression levels of LOXs and MMPmRNA in HA tissues were up-regulated, which was consistent with the results of western blotting


    .


    Compared with OA ligaments, HA ligaments have looser structure, wider gaps, more fractures, blood cell deposition and local hypertrophy between fibers

    The study concluded that the ligament metabolism of HA patients is more complicated than that of OA patients, and the ligaments of HA patients have a stronger healing and destruction process
    .
    This pathology is related to unbalanced inflammatory factors caused by iron overload and repeated intra-articular bleeding


    .


    The ligament metabolism of HA patients is more complicated than that of OA patients, and the ligaments of HA patients have a stronger healing and destruction process


    Zheng, L, Luo, D, Li, J, et al.


    Pathological changes and expression of lysine oxidases and matrix metalloproteinases -1, -2, and -3 in ligaments of patients with haemophilic arthritis .


    Pathological changes and expression of lysine oxidases and matrix metalloproteinases -1, -2, and -3 in ligaments of patients with haemophilic arthritis in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.